New Orleans

Southeastern Grocers announces donation of $225,000 for children’s hospitals ahead of National Cancer Research Month

Retrieved on: 
Thursday, April 27, 2023
Other Philanthropy, Supermarket, Convenience Store, Food, Beverage, Philanthropy, Fund Raising, Foundation, Retail, Harveys Supermarkets, National Cancer Institute (Egypt), Multimedia, Research, Hospital, Winn-Dixie, Patient, Child, SEG, Johns Hopkins, Health, New Orleans, Southeastern Grocers

Southeastern Grocers Inc. (SEG), parent company and home of Fresco y Más, Harveys Supermarket and Winn-Dixie grocery stores, today announced the donation of $225,000 to nine Southeast children’s hospitals ahead of National Cancer Research Month.

Key Points: 
  • Southeastern Grocers Inc. (SEG), parent company and home of Fresco y Más, Harveys Supermarket and Winn-Dixie grocery stores, today announced the donation of $225,000 to nine Southeast children’s hospitals ahead of National Cancer Research Month.
  • View the full release here: https://www.businesswire.com/news/home/20230427005213/en/
    Southeastern Grocers announces the donation of $225,000 to nine Southeast children’s hospitals, ahead of National Cancer Research Month.
  • All donations made during the grocer’s two-week community donation program will go toward each facility’s pediatric specialty programs, family centered support, therapeutic activities, research, child advocacy and other vital programs.
  • Raymond Rhee, Chief People Officer for Southeastern Grocers, said, “We recognize the critical importance of supporting the most vulnerable members of our communities – children.

Silverback Distillery Mother Daughter Duo Sweeps the 2023 New Orleans Bourbon Festival Bringing Home Six Awards

Retrieved on: 
Monday, April 24, 2023
Honey, American whiskey, Gorilla, New Orleans, Film industry, Festival

NEW ORLEANS, April 24, 2023 /PRNewswire/ -- For the first time in New Orleans Bourbon Festival history, one distillery took home six awards, including the coveted Best in Festival award.

Key Points: 
  • NEW ORLEANS, April 24, 2023 /PRNewswire/ -- For the first time in New Orleans Bourbon Festival history, one distillery took home six awards, including the coveted Best in Festival award.
  • Silverback Distillery, the nation's only mother daughter distiller duo wins big at New Orleans Bourbon Festival.
  • In 2018 Silverback took home "Best Bourbon Under 4 Years" with their Blackback Bourbon and "Best American Whiskey" for their Honey Rye.
  • Silverback Distillery brought home six awards, including Best in Fest for the Alpha Series Bourbon.

Adverum Biotechnologies Presents Nonclinical Data at the 2023 ARVO Annual Meeting Supporting Potential for Staggered Bilateral Administration of Ixo-vec

Retrieved on: 
Sunday, April 23, 2023
Consensus, McKibbin, ARVO, Adverum Biotechnologies, NOAEL, AMD, Eye, LUNA, Inflammation, Publication, George Loewenstein, Burak Eldem, Administration, Incidence, JAMA Ophthalmology, Patient, Vance DeGeneres, Association for Research in Vision and Ophthalmology, Research, No-observed-adverse-effect level, Visual acuity, New Orleans, Pharmaceutical industry, Vaccine, Publishing, Ophthalmology, NHP

REDWOOD CITY, Calif., April 23, 2023 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced nonclinical data supporting the two doses of ixoberogene soroparvovec (Ixo-vec, formerly referred to as ADVM-022) being evaluated in the Phase 2 LUNA trial and the potential for staggered, bilateral administration in the treatment of wet AMD. The data were featured in an oral presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting in New Orleans, Louisiana.

Key Points: 
  • The data were featured in an oral presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting in New Orleans, Louisiana.
  • Administration of a single intravitreal dose of Ixo-vec in the second eye resulted in peak aflibercept levels that are within the targeted therapeutic range.
  • Despite elevated systemic humoral response after first eye injection, second eye total antibodies were undetectable prior to injection of Ixo-vec dose in the second eye.
  • The presentation will be made available on the Publications page of the Adverum website.

Janssen to Highlight Innovation in Retinal Pipeline at the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting

Retrieved on: 
Friday, April 21, 2023
Abstract (summary), ARVO, IRD, AMD, Retinitis pigmentosa, Geographic atrophy, Quality of life, Janssen, Research, Paratriathlon, GA, GTPase, Patient, Peripheral vision, Association for Research in Vision and Ophthalmology, Johnson & Johnson, RPGR, New Orleans, Janssen Pharmaceuticals, Pharmaceutical industry, Retina, Ophthalmology

RARITAN, N.J., April 21, 2023 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that five company-sponsored presentations will be featured during the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting in New Orleans from April 23-27, 2023. Janssen presentations will include updates from the Phase 1/2 MGT009 trial for investigational gene therapy botaretigene sparoparvovec (bota-vec, formerly AAV-RPGR) in patients with the inherited retinal disease (IRD) X-linked retinitis pigmentosa (XLRP) associated with the retinitis pigmentosa GTPase regulator (RPGR) gene, and pooled safety analysis data from two Phase 1 trials of the investigational gene therapy JNJ-81201887 (JNJ-1887); one trial in patients with geographic atrophy (GA), a late-stage and severe form of age-related macular degeneration (AMD) and one trial in wet AMD (Abstracts #5446 and #732-C0314).1,2

Key Points: 
  • Important new data on Janssen's investigational gene therapy portfolio, including botaretigene sparoparvovec (bota-vec) and JNJ-1887, will be presented
    RARITAN, N.J., April 21, 2023 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that five company-sponsored presentations will be featured during the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting in New Orleans from April 23-27, 2023.
  • In this new era of innovation, we're taking a cutting-edge approach to saving sight through groundbreaking technologies such as gene therapy, and we're thrilled to showcase some of this research at this year's ARVO annual meeting," said James List, M.D., Ph.D., Global Therapeutic Area Head, whose team oversees a portfolio of programs including Retina at Janssen Research & Development, LLC.
  • "We are on a bold mission to restore and preserve vision for people living with retinal diseases, and these important data bring us one step closer to building a brighter future for the patients we serve."
  • Abstracts can also be found on the ARVO Annual Meeting website.

Ocugen to Present at Association for Research in Vision and Ophthalmology 2023 Annual Meeting

Retrieved on: 
Thursday, April 20, 2023
Vaccine, Medicine, ARVO, Vance DeGeneres, Association for Research in Vision and Ophthalmology, New Orleans, DME, Stargardt disease, CSO, Retinitis pigmentosa, Voretigene neparvovec, Diabetic retinopathy, Doctor of Philosophy, Development, Patient, Macular degeneration, Treatment, The Association, News, Leber congenital amaurosis, Retina, Pharmaceutical industry, Stargardt, DR, Ophthalmology, Research

“We are thrilled to share more detail on our unique modifier gene therapy platform, as well as our novel biologics ophthalmic product pipeline with the professional community at ARVO,” commented Arun Upadhyay, PhD, Chief Scientific Officer and Head of Research, Development and Medical at Ocugen.

Key Points: 
  • “We are thrilled to share more detail on our unique modifier gene therapy platform, as well as our novel biologics ophthalmic product pipeline with the professional community at ARVO,” commented Arun Upadhyay, PhD, Chief Scientific Officer and Head of Research, Development and Medical at Ocugen.
  • “It is especially exciting to be at ARVO just following positive preliminary safety and efficacy results from the Phase 1/2 trial of OCU400 for the treatment of retinitis pigmentosa.
  • We look forward to highlighting this most recent news along with the work we are doing across our ophthalmology portfolio to combat hard-to-treat blindness diseases affecting millions of patients globally,” Dr. Upadhyay concluded.
  • Title: Modifier Gene Approach Using OCU410 for Dry AMD Therapy: One Gene—Multiple Targets
    Title: Ocugen—OCU400—Modifier Gene Therapy for Treatment of Inherited Retinal Diseases: Retinitis Pigmentosa & Leber Congenital Amaurosis
    Presenter: Arun Upadhyay, PhD, CSO and Head of Research, Development and Medical, Ocugen
    Title: Ocugen—OCU200—A Novel Biologic for the Treatment of DME, DR, and Wet AMD

The American College of Trust and Estate Counsel (ACTEC) Elects 23 New Fellows to the College

Retrieved on: 
Thursday, April 13, 2023
Teaching, Writing, Lawyer, American College of Trust and Estate Counsel, Trust, United States Army War College International Fellows Hall of Fame, Fellows, Regent, American College, New Orleans, Real estate, College

WASHINGTON, April 13, 2023 /PRNewswire-PRWeb/ -- The Board of Regents of The American College of Trust and Estate Counsel (ACTEC) convened during the College's 2023 Annual Meeting in New Orleans, Louisiana, to consider nominations for a new class of ACTEC Fellows. The College is pleased to announce 23 individuals were elected. This select group includes 19 Fellows, one International Fellow from Singapore, and three Fiduciary Counsel Fellows. Of those elected, three are graduates of the Mid-Atlantic Fellows Institute; one is a graduate of the Florida Fellows Institute; one is a graduate of the Heart of America Fellows Institute; one is a graduate of the New England Fellows Institute; one is a graduate of the Southeast Fellows Institute; and two are former participants in the Dennis I. Belcher Young Leaders Program.

Key Points: 
  • The Board of Regents of The American College of Trust and Estate Counsel announces 23 individuals were elected into the College.
  • WASHINGTON, April 13, 2023 /PRNewswire-PRWeb/ -- The Board of Regents of The American College of Trust and Estate Counsel (ACTEC) convened during the College's 2023 Annual Meeting in New Orleans, Louisiana, to consider nominations for a new class of ACTEC Fellows.
  • This select group includes 19 Fellows, one International Fellow from Singapore, and three Fiduciary Counsel Fellows.
  • "On behalf of ACTEC, we welcome these experienced trust and estate lawyers to the College, and we are looking forward to their contributions."

America’s Blood Centers Announces Inaugural Blood Advocacy Week to Promote the Value of Blood to Patients, Communities, and our Healthcare System

Retrieved on: 
Wednesday, April 5, 2023
National Hemophilia Foundation, Gulf Coast Regional Blood Center, Health care, Fresenius (company), Thrive, Capitol Hill, Civil Air Patrol, Food, America's Blood Centers, Vitalant, LifeSouth Community Blood Centers, Whitman-Walker Health, Blood Assurance, Organization, Hospital, Patient, Korea Disease Control and Prevention Agency, ABC, Horizon Fuel Cell Technologies, Regulation of tobacco by the U.S. Food and Drug Administration, GLAAD, New Orleans, Social media, Pharmaceutical industry, Medical device, Blood

Washington, DC, April 05, 2023 (GLOBE NEWSWIRE) -- America’s Blood Centers (ABC), the national organization of community-based, independent blood centers that supply 60 percent of the nation’s blood supply, today announced the inaugural Blood Advocacy Week occurring April 24th-28th.

Key Points: 
  • Washington, DC, April 05, 2023 (GLOBE NEWSWIRE) -- America’s Blood Centers (ABC), the national organization of community-based, independent blood centers that supply 60 percent of the nation’s blood supply, today announced the inaugural Blood Advocacy Week occurring April 24th-28th.
  • Dozens of diverse partners have signed on to help promote the value of blood through taking part in Blood Advocacy Week.
  • They are being joined by community blood centers across the country, including Blood Assurance, Carter BloodCare, Community Blood Center (Appleton), Community Blood Center-Dayton, the Blood Center (New Orleans), Gulf Coast Regional Blood Center, Houchin Community Blood Bank, LIFELINE Blood Services, LifeServe Blood Center, LifeSouth Community Blood Centers, MEDIC Regional Blood Center, Miller-Keystone Blood Center, Rock River Valley Blood Center, San Diego Blood Bank, Shepeard Community Blood Center, South Texas Blood and Tissue, The Blood Connection, Versiti, and Vitalant.
  • Founded in 1962, America’s Blood Centers is the national organization bringing together community-based, independent blood centers.

Southeastern Grocers launches third annual children’s hospital community donation program

Retrieved on: 
Wednesday, April 12, 2023
Supply Chain Management, Philanthropy, Retail, Other Philanthropy, Supermarket, Fund Raising, Food, Beverage, Dance, Harveys Supermarkets, Pediatrics (journal), American Academy, Multimedia, Research, Cardiology, Hospital, Winn-Dixie, Patient, Child, SEG, Reading, Nursing care plan, Johns Hopkins, New Orleans, Nursing, Southeastern Grocers, Dickie Noles

View the full release here: https://www.businesswire.com/news/home/20230412005308/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230412005308/en/
    Southeastern Grocers' community donation campaign will support the lifesaving work of nine Southeast hospitals, including Children’s of Mississippi whose pediatric cardiologists discovered and repaired two holes in Nolee’s heart when she was only 5 months old.
  • As a result of the remarkable care she received at her local children’s hospital, Nolee (pictured here) is now a thriving 10-year-old who enjoys dancing, reading and making TikTok videos.
  • All donations made during the program will support the local children’s hospital partner and aid young patients and their families as they work towards healing and recovery.
  • Raymond Rhee, Chief People Officer for Southeastern Grocers, said, “At Southeastern Grocers, we are dedicated to giving back to our local communities and believe every child deserves access to the best possible care.

MatriSys Bioscience Co-Founder Richard Gallo, MD, PhD Honored by AAD and AAAAI

Retrieved on: 
Monday, March 20, 2023
Eugene, Piper LBP, American Academy of Dermatology, Skin, BOCA, Atopic dermatitis, American Academy, Research, AAD, AAAAI, Innovation, Health, New Orleans, Pharmaceutical industry, Medical device, Bedside

BOCA RATON, Fla., March 20, 2023 /PRNewswire/ -- MatriSys BioScience, a private, clinical-stage pharmaceutical company focused on developing live biotherapeutic products (LBPs) for chronic dermatologic indications, today announced that its scientific co-founder, Dr. Richard Gallo, received the Eugene J Van Scott award for Innovative Therapy of the Skin from the American Academy of Dermatology (AAD).

Key Points: 
  • BOCA RATON, Fla., March 20, 2023 /PRNewswire/ -- MatriSys BioScience, a private, clinical-stage pharmaceutical company focused on developing live biotherapeutic products (LBPs) for chronic dermatologic indications, today announced that its scientific co-founder, Dr. Richard Gallo, received the Eugene J Van Scott award for Innovative Therapy of the Skin from the American Academy of Dermatology (AAD).
  • This award was created in 2007 to recognize innovation in the treatment of skin diseases and conditions.
  • Dr. Gallo will be presenting the Philip Frost Leadership lecture during the AAD conference plenary session in New Orleans LA on March 19.
  • The application of Dr. Gallo's research into the microbiome of the skin provides new opportunities to advance patient care in atopic dermatitis and other chronic conditions.

Ibotta Becomes Brand Sponsor of Logan Sargeant During His Debut Formula 1 Season

Retrieved on: 
Thursday, March 16, 2023
New Orleans, Leach, Ecosystem, Partnership, Williams, F1, History, New Orleans Pelicans, Cryptocurrency, Sport, Ibotta

Sargeant, a Fort Lauderdale, FL native, first got behind the wheel of a go-kart at five years old, kicking off his motorsport journey.

Key Points: 
  • Sargeant, a Fort Lauderdale, FL native, first got behind the wheel of a go-kart at five years old, kicking off his motorsport journey.
  • Seventeen years later, Sargeant has landed one of only 20 highly coveted F1 seats, as a driver for the Williams Racing team.
  • To have a respected brand like Ibotta support me in this new chapter is truly rewarding,” said Sargeant.
  • Ibotta plans to use its partnership with Logan for business development purposes, to expand international awareness of the Ibotta brand, and to attract new, younger audiences to its franchise.